Sartorius AktiengesellschaftSARTF
Price as of · delayed, not real-time
A life science research and biopharmaceutical supplier, this German firm provides laboratory instruments, consumables, and bioprocess solutions used in drug development and manufacturing. Its portfolio spans cell culture media, filtration systems, and analytical tools, making it a key vendor to pharmaceutical and academic research clients. Investors track the company for its exposure to the growing biologics and cell therapy markets.
Congressional Interest in Sartorius Aktiengesellschaft (SARTF)
1 member of Congress has disclosed 1 trade in Sartorius Aktiengesellschaft (SARTF), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading SARTF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-03 | JAMES B. RENACCI | buy | $1K-$15K |